BIOA

BioAge Labs Inc. Common Stock (BIOA)

Stock · NASDAQ · Health Care

$9.65as of 8/28/2026

Active signals

No technical signal is currently active for this symbol.

Resistance level
$16.1
Industry
Biotechnology: Pharmaceutical Preparations

BioAge Labs Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • BIOA
    BioAge Labs Inc. Common Stock
    $9.65
    ▼ 4.27%
    Market cap $479.20MP/E
  • QTTB
    Q32 Bio Inc. Common Stock
    $15.01
    ▼ 7.06%
    Market cap $451.37MP/E 15.71
    $1.62$23.57
  • SGMT
    Sagimet Biosciences Inc. Series A Common Stock
    $10.55
    ▼ 1.86%
    Market cap $441.53MP/E
    $4.5$11.15
  • ARVN
    Arvinas Inc. Common Stock
    $9.16
    ▼ 0.87%
    Market cap $520.04MP/E 62.96
    $6.97$14.51
  • PRTA
    Prothena Corporation plc Ordinary Shares
    $9.35
    ▲ 2.86%
    Market cap $436.10MP/E
    $7.73$11.8
  • BNTC
    Benitec Biopharma Inc. Common Stock
    $12.51
    ▼ 1.30%
    Market cap $417.41MP/E
    $9.85$16.76
  • KMDA
    Kamada Ltd. Ordinary Shares
    $8.29
    ▲ 0.36%
    Market cap $417.07MP/E 20.65
    $6.5$9.35

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held
33.73M
Total value held
$581.41M
Institutional holders
142
Top holders this quarter
  • Unknown3.23M
  • Unknown2.89M
  • Unknown2.29M
  • Unknown2.27M
  • Unknown2.09M
  • Unknown1.75M
  • Unknown1.65M
  • Unknown1.35M
  • Unknown1.33M
  • Unknown1.20M

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.